BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4709950)

  • 21. Letter: Serum-copper in Hodgkin's disease before and after herpes zoster.
    Thorling EB; Thorling K
    Lancet; 1974 Dec; 2(7893):1396-7. PubMed ID: 4143363
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum copper assay as a biochemical marker to assess the response to therapy in Hodgkin's disease.
    Kesava Rao KV; Shetty PA; Bapat CV; Jussawalla DJ
    Indian J Cancer; 1977 Dec; 14(4):320-4. PubMed ID: 612553
    [No Abstract]   [Full Text] [Related]  

  • 23. Value of laboratory indicators in Hodgkin's disease: preliminary results.
    Ray GR; Wolf PH; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum copper levels in lymphoma and leukemia. Special reference to Hodgkin's disease.
    Hrgovcic M; Tessmer CF; Minckler TM; Mosier B; Taylor GH
    Cancer; 1968 Apr; 21(4):743-55. PubMed ID: 4868473
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma iron and copper in Hodgkin's disease. A comparison with other laboratory indicators.
    Gobbi PG; Scarpellini M; Minoia C; Pozzoli L; Perugini S
    Haematologica; 1979 Aug; 64(4):416-32. PubMed ID: 121577
    [No Abstract]   [Full Text] [Related]  

  • 26. Ceruloplasmin in Hodgkin's disease.
    Koprivová H; Dienstbier Z; Sámal M; Foltýnová V
    Neoplasma; 1982; 29(3):333-40. PubMed ID: 7133228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    Fuks Z; Strober S; Kaplan HS
    N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Blood iron and blood copper in acute and chronic leukemia and in Hodgkin's disease].
    RECHENBERGER J
    Dtsch Z Verdau Stoffwechselkr; 1957 Apr; 17(2):78-85. PubMed ID: 13437842
    [No Abstract]   [Full Text] [Related]  

  • 29. Abnormal blood chemistry values in Hodgkin's disease. Lack of correlation with staging of disease.
    Levine PH
    JAMA; 1972 Jun; 220(13):1734-5. PubMed ID: 5067607
    [No Abstract]   [Full Text] [Related]  

  • 30. Hodgkin's disease: considerable progress and more to be achieved.
    Mathé G; Tubiana M
    Ser Haematol; 1973; 6(2):244-69. PubMed ID: 4361523
    [No Abstract]   [Full Text] [Related]  

  • 31. Elevated serum Cu in Hodgkin's disease and inhibitory effects of ceruloplasmin on lymphocyte response in vitro.
    Larsen B; Heron I; Thorling EB
    Eur J Cancer (1965); 1980 Mar; 16(3):415-21. PubMed ID: 6445273
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hodgkin's disease, stage IVb: survival for 12 years (author's transl)].
    Schirmeister J; Krieger G
    Med Klin; 1977 Apr; 72(15):637-41. PubMed ID: 853978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serum ferritin and other biological parameters as indicators of tumor activity in Hodgkin's disease].
    Hermosa V; Mazo E; Baró J; Castillo E; Cordovilla JJ; Carril J; Zubizarreta A
    Sangre (Barc); 1985; 30(2):154-8. PubMed ID: 2409612
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum trace elements and Cu/Zn ratio in malignant lymphomas in children.
    Gupta SK; Shukla VK; Gupta V; Gupta S
    J Trop Pediatr; 1994 Jun; 40(3):185-7. PubMed ID: 8078119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of some humoral and cytological indices in active stages of Hodgkin's disease].
    Barbui T; Dini E; Chisesi T; Corà R; Franchi F; Cazzavillan M; Battista R
    Haematologica; 1972; 57(9):488-92. PubMed ID: 4125445
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hodgkin's disease. Lymphoadenography, cupremia and sideremia].
    Weissleder H; Marongiu F
    Prensa Med Argent; 1966 May; 53(18):1001-7. PubMed ID: 5916206
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prognosis in Hodgkin's disease].
    Armata J
    Pol Tyg Lek; 1972 Aug; 27(35):1374-6. PubMed ID: 4342830
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum alpha-1-acid-glycoprotein, haptoglobin and C3 in Hodgkin's disease. A comparison with other acute-phase indicators.
    Gobbi PG; Merlini G; Parrinello GA; Cavalli P; Ascari E
    Acta Haematol; 1982; 67(4):255-62. PubMed ID: 6180585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination chemotherapy of Hodgkin's disease in private practice.
    Greenberg LH; Wong S; Richardson AP; Dollinger MR
    JAMA; 1972 Jul; 221(3):261-3. PubMed ID: 5067790
    [No Abstract]   [Full Text] [Related]  

  • 40. Membrane difference in peripheral blood lymphocytes from patients with chronic lymphocytic leukemia and Hodgkin's disease.
    Mintz U; Sachs L
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):2428-32. PubMed ID: 1056037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.